Evidence map›Paper›PMID 22278364›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2012

Prediagnostic 25-hydroxyvitamin D, VDR and CASR polymorphisms, and survival in patients with colorectal cancer in western European ppulations.

Veronika Fedirko, Elio Riboli, Anne Tjønneland, Pietro Ferrari, Anja Olsen, H Bas Bueno-de-Mesquita, Fränzel J B van Duijnhoven, Teresa Norat, Eugène H J M Jansen, Christina C Dahm and 37 more

Open access · greenAbstract readComparative Study
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 9 pooled it
9.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 9 syntheses or guidelines pooled it, 133 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Trial
  11. Plasma 25-Hydroxyvitamin D Levels and Survival in Patients with Advanced or Metastatic Colorectal Cancer: Findings from CALGB/SWOG 80405 (Alliance).Clinical cancer research : an official journal of the American Association for Cancer Research · 2019
    Trial
  12. Trial
  13. Trial
  14. Article
  15. Review
  16. Review
  17. The Relationship betweenGlobal medical genetics · 2024
    Article
  18. Article
  19. Article
  20. Prediagnostic 25-Hydroxyvitamin D in Association with Cancer-specific and All-cause Mortality among Low-income, Non-Hispanic Black Americans with Colorectal Cancer.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

47 authors at 4 institutions in 4 countries.

Veronika FedirkoNutritional Epidemiology Group, International Agency for Research on Cancer, 150 Cours Albert Thomas, Lyon, France. fedirkov@iarc.fr
Elio Riboli
Anne Tjønneland
Pietro Ferrari
Anja Olsen
H Bas Bueno-de-Mesquita
Fränzel J B van Duijnhoven
Teresa Norat
Eugène H J M Jansen
Christina C Dahm
Kim Overvad
Marie-Christine Boutron-Ruault
Françoise Clavel-Chapelon
Antoine Racine
Annekatrin Lukanova
Birgit Teucher
Heiner Boeing
Krasimira Aleksandrova
Antonia Trichopoulou
Vassiliki Benetou
Dimitrios Trichopoulos
Sara Grioni
Paolo Vineis
Salvatore Panico
Domenico Palli
Rosario Tumino
Peter D Siersema
Petra H Peeters
Guri Skeie
Magritt Brustad
Maria-Dolores Chirlaque
Aurelio Barricarte
Jose Ramón Quirós
Maria José Sánchez
Miren Dorronsoro
Catalina Bonet
Richard Palmqvist
Göran Hallmans
Timothy J Key
Francesca Crowe
Kay-Tee Khaw
Nick Wareham
Isabelle Romieu
James McKay
Petra A Wark
Dora Romaguera
Mazda Jenab
Imperial College London · GBDanish Cancer Society · DKNational Institute for Public Health and the Environment · NLInserm · FR

Funding

Cancer Research UK 14136Cancer Research UK A11692Medical Research Council G0401527Medical Research Council G1000143Medical Research Council MC_U106179471
6 · The paper itself

Abstract

backgroundIndividuals with higher blood 25-hydroxyvitamin D [25(OH)D] levels have a lower risk of developing colorectal cancer (CRC), but the influence of 25(OH)D on mortality after CRC diagnosis is unknown.

methodsThe association between prediagnostic 25(OH)D levels and CRC-specific (N = 444) and overall mortality (N = 541) was prospectively examined among 1,202 participants diagnosed with CRC between 1992 and 2003 in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Multivariable Cox proportional hazards models were used to calculate HRs and corresponding 95% CIs according to 25(OH)D quintiles and genetic variation within the VDR and CASR genes. Potential dietary, lifestyle, and metabolic effect modifiers were also investigated.

resultsThere were 541 deaths, 444 (82%) due to CRC. Mean follow-up was 73 months. In multivariable analysis, higher 25(OH)D levels were associated with a statistically significant reduction in CRC-specific (P(trend) = 0.04) and overall mortality (P(trend) = 0.01). Participants with 25(OH)D levels in the highest quintile had an adjusted HR of 0.69 (95% CI: 0.50-0.93) for CRC-specific mortality and 0.67 (95% CI: 0.50-0.88) for overall mortality, compared with the lowest quintile. Except for a possible interaction by prediagnostic dietary calcium intake (P(interaction) = 0.01), no other potential modifying factors related to CRC survival were noted. The VDR (FokI and BsmI) and CASR (rs1801725) genotypes were not associated with survival.

conclusionsHigh prediagnostic 25(OH)D levels are associated with improved survival of patients with CRC. IMPACT: Our findings may stimulate further research directed at investigating the effects of blood vitamin D levels before, at, and after CRC diagnosis on outcomes in CRC patients.

Indexed as

Polymorphism, GeneticCase-Control StudiesColorectal NeoplasmsDNAFemaleFollow-Up StudiesGenotypeHumansMaleMiddle AgedPolymerase Chain ReactionPrognosisProspective StudiesReceptors, CalcitriolReceptors, Calcium-SensingRisk Factors25-hydroxyvitamin DCASR protein, humanDNAReceptors, CalcitriolReceptors, Calcium-SensingVitamin D

Identifiers

PMID22278364
PMCPMC3378514
OpenAlexW2163577786

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.